In 2021, A-share R&D expenses will exceed 1,200 billion yuan, and pharmaceutical and biological companies are "most invested"_Shenzhen Hotline Post date May 6, 2022 — 11:48 Post Lock Read More In 2021, A-share R&D expenses will exceed 1.2 trillion yuan, and pharmaceutical and biological companies are "most invested" Post date May 6, 2022 — 06:50 Post Lock Read More Zhaori Technology’s net profit in 2021 is 26.5796 million year-on-year, and chairman Wei Kaiyan’s salary is 1.7915 million – yqqlm Post date April 27, 2022 — 00:13 Post Lock Read More
In 2021, A-share R&D expenses will exceed 1.2 trillion yuan, and pharmaceutical and biological companies are "most invested" Post date May 6, 2022 — 06:50 Post Lock Read More Zhaori Technology’s net profit in 2021 is 26.5796 million year-on-year, and chairman Wei Kaiyan’s salary is 1.7915 million – yqqlm Post date April 27, 2022 — 00:13 Post Lock Read More
Zhaori Technology’s net profit in 2021 is 26.5796 million year-on-year, and chairman Wei Kaiyan’s salary is 1.7915 million – yqqlm Post date April 27, 2022 — 00:13 Post Lock Read More
Caishen.CoCaishen.Co